Durham, N.C. — For the past 20 years, cord blood stem cell transplants have been used to treat leukemia and other blood diseases.
Cord blood is most often used in children because the blood comes from the umbilical cord, which holds a limited quantity, according to the National Marrow Donor Program. Cord blood also doesn't have to be as close a blood or tissue match as bone marrow does.
Duke University Medical Center is a pioneer in cord blood stem cell transplants. Doctors have worked mainly with children, but not entirely.
Gayle Searls is proof the treatment can be used in adults as well. Twelve years ago, Searls was Duke’s first adult cord blood transplant patient.
In 1996, Searls began feeling unusual fatigue. She would bruise easily, and her lymph nodes were swelling.
“I was literally at work that day and in the hospital that night with leukemia,” Searls said.
Searls was diagnosed with acute lymphacytic leukemia that required a matching bone marrow donor, but none could be found.
At the time, doctors at Duke were just learning how to use the blood transplant and figuring out who it would best work for, said Dr. Joanne Kurtzberg, director of the Stem Cell Program at Duke.
Only 14 percent of donor units have enough cells to treat an adult, Kurtzberg said. Chemotherapy and radiation kill bone marrow, which allows the new stem cells to work.
“The transplant actually rescues the bone marrow after the therapy kills it,” Kurtzberg said.
After seven weeks in the hospital, Searls went home. A month later, she was off all medication and has stayed that way.
“I would have died if I had not had the stem cells – the cord blood stem cells,” Searls said.
Searls now works at Carolina's Cord Blood Bank – the source of her cure.
“She really is an example that cord blood can help adults,” Kurtzberg said.
Besides treating blood diseases, doctors have learned that stem cells from umbilical cord blood also help repair tissue damage in several organs like the heart. Researchers are trying to better understand how that happens.
Cord blood can be used to treat adult leukemia
- Reporter: Allen Mask, M.D.
- Producer: Rick Armstrong
- Web Editor: Kathy Hanrahan
RELATED TOPICS: Duke University, Stem Cell Research
Copyright 2011 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
10 Comments
Want to Live Downtown Raleigh- condos for $220k!
Travel NC By Train: Click for Daily Schedules!
AlarmForce VideoRelay Security as low as $10/mo*
Save Money On Your Energy Bill - togetherwesave.com
Bundle & Save! Get free delivery of a PODS® container - See how
advertisement





WRAL.com welcomes your comments on this story. All comments are moderated prior to publication based on our posting guidelines. Please review them prior to posting and if your message is not approved.
This story is closed for comments. Comments on WRAL.com news stories are accepted and moderated between the hours of 8 a.m. and 8 p.m. Monday through Friday.
I think it is already clear that stem cells from umbilical cord blood are clearly beneficial to many patients (as an example, the National Marrow Donor Program facilitated 600 transplants in 2007) and the number of patients and diseases benefitting will only increase. The expansion of research into other cells from the placenta or umbilical cord does hold great promise because of the wide availability of these tissues. There is much more information at http://www.marrow.org/ Getting into the donor database is easier than ever.
August 26, 2008 12:52 p.m.
Bottom line: Duke, along with and other top-flight medical centers, has shown that stem cells have curative potential for a variety of disorders in both children and adults. There are ethical issues to be addressed regarding the use of embryonic stem cells, but using stem cells obtained from the placenta of women who consent to this is one way to tap into a resource that would otherwise serve no benefit.
We must continue to conduct clinical research into the value of this therapy. Without rigorous research, we cannot conclusively state that there is a clear benefit to use of umbilical cord blood to treat disease. Without financial support from the government and from other sources, this research cannot be conducted, and statements as to the efficacy of UCB transplants cannot be substantiated.
August 25, 2008 6:02 p.m.
August 25, 2008 5:06 p.m.
August 25, 2008 4:11 p.m.
August 25, 2008 3:54 p.m.